Related Experiment Videos
Human synaptic proteins with a heterogeneous distribution in cerebellum and visual cortex
1Department of Psychiatry, University of British Columbia, Vancouver, Canada.
Brain Research
|April 23, 1993
Summary
New SP antibodies identify distinct synaptic proteins in the human brain, aiding research into neuropsychiatric disorders and synaptic pathology. These tools help define synaptic heterogeneity and study disease-related molecular disruptions.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Synaptic pathology is implicated in various neuropsychiatric disorders.
- Previous studies using EP10 antibody showed reduced 38 kDa synaptophysin-like protein in Alzheimer's disease.
Purpose of the Study:
- To develop and characterize novel antibodies (SP antibodies) for studying synaptic proteins in the human brain.
- To investigate synaptic heterogeneity and identify molecular markers for neuropsychiatric conditions.
Main Methods:
- Generation of SP antibodies using human brain proteins immunoprecipitated by EP10 as immunogen.
- Hybridoma screening via sequential ELISA and immunocytochemistry.
- Characterization of antibody reactivity against different molecular weight antigens.
Main Results:
- Sixteen SP antibodies were obtained, clustering antigens into five groups based on molecular weight (38 kDa, 16 kDa, 34-36 kDa, 26-27 kDa, and a complex 38-40+ kDa group).
- Antibodies identified synaptophysin-like, potential synaptobrevin, and novel synaptic antigens with specific localizations in the cerebellum.
- Co-localization of 16 kDa and 38 kDa antigens was observed in human brain tissue.
Conclusions:
- SP antibodies provide valuable tools for dissecting synaptic heterogeneity in the human brain.
- These antibodies can be used to study synaptic proteins and their alterations in pathological conditions like neuropsychiatric diseases.